These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31810173)

  • 1. The PPARδ Agonist GW501516 Improves Lipolytic/Lipogenic Balance through CPT1 and PEPCK during the Development of Pre-Implantation Bovine Embryos.
    Idrees M; Xu L; El Sheikh M; Sidrat T; Song SH; Joo MD; Lee KL; Kong IK
    Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
    Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
    Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor δ improves porcine blastocyst hatching via the regulation of fatty acid oxidation.
    Guo J; Lu WF; Liang S; Choi JW; Kim NH; Cui XS
    Theriogenology; 2017 Mar; 90():266-275. PubMed ID: 28166979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.
    Krämer DK; Al-Khalili L; Guigas B; Leng Y; Garcia-Roves PM; Krook A
    J Biol Chem; 2007 Jul; 282(27):19313-20. PubMed ID: 17500064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of PPARdelta up-regulates fatty acid oxidation and energy uncoupling genes of mitochondria and reduces palmitate-induced apoptosis in pancreatic beta-cells.
    Wan J; Jiang L; Lü Q; Ke L; Li X; Tong N
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1567-72. PubMed ID: 20040361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist.
    Sprecher DL; Massien C; Pearce G; Billin AN; Perlstein I; Willson TM; Hassall DG; Ancellin N; Patterson SD; Lobe DC; Johnson TG
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):359-65. PubMed ID: 17110604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome.
    Tanaka T; Yamamoto J; Iwasaki S; Asaba H; Hamura H; Ikeda Y; Watanabe M; Magoori K; Ioka RX; Tachibana K; Watanabe Y; Uchiyama Y; Sumi K; Iguchi H; Ito S; Doi T; Hamakubo T; Naito M; Auwerx J; Yanagisawa M; Kodama T; Sakai J
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15924-9. PubMed ID: 14676330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PPARdelta agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cells.
    Dimopoulos N; Watson M; Green C; Hundal HS
    FEBS Lett; 2007 Oct; 581(24):4743-8. PubMed ID: 17869249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation.
    Li Q; Li L; Wang F; Chen J; Zhao Y; Wang P; Nilius B; Liu D; Zhu Z
    Pflugers Arch; 2013 Sep; 465(9):1303-16. PubMed ID: 23605066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Wnt Signaling During In-Vitro Bovine Blastocyst Development and Maturation in Synergism with PPARδ Signaling.
    Sidrat T; Khan AA; Idrees M; Joo MD; Xu L; Lee KL; Kong IK
    Cells; 2020 Apr; 9(4):. PubMed ID: 32283810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of PPARδ signaling improves skeletal muscle oxidative metabolism and endurance function in an animal model of ischemic left ventricular dysfunction.
    Zizola C; Kennel PJ; Akashi H; Ji R; Castillero E; George I; Homma S; Schulze PC
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1078-85. PubMed ID: 25713305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARδ activation in human myotubes increases mitochondrial fatty acid oxidative capacity and reduces glucose utilization by a switch in substrate preference.
    Feng YZ; Nikolić N; Bakke SS; Boekschoten MV; Kersten S; Kase ET; Rustan AC; Thoresen GH
    Arch Physiol Biochem; 2014 Feb; 120(1):12-21. PubMed ID: 23991827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of peroxisome proliferators-activated receptor δ (PPARδ) promotes blastocyst hatching in mice.
    Kang HJ; Hwang SJ; Yoon JA; Jun JH; Lim HJ; Yoon TK; Song H
    Mol Hum Reprod; 2011 Oct; 17(10):653-60. PubMed ID: 21511721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Effect of Unsaturated Fatty Acids on Palmitic Acid-Induced Toxicity in Skeletal Muscle Cells is not Mediated by PPARδ Activation.
    Tumova J; Malisova L; Andel M; Trnka J
    Lipids; 2015 Oct; 50(10):955-64. PubMed ID: 26255030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective PPARdelta agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study.
    Jucker BM; Yang D; Casey WM; Olzinski AR; Williams C; Lenhard SC; Legos JJ; Hawk CT; Sarkar SK; Newsholme SJ
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1256-64. PubMed ID: 17726146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator activated receptor delta (PPARdelta) agonist but not PPARalpha corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells.
    Djouadi F; Aubey F; Schlemmer D; Bastin J
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1791-7. PubMed ID: 15613406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARdelta is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction.
    Ravnskjaer K; Frigerio F; Boergesen M; Nielsen T; Maechler P; Mandrup S
    J Lipid Res; 2010 Jun; 51(6):1370-9. PubMed ID: 19965574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome.
    Luquet S; Lopez-Soriano J; Holst D; Gaudel C; Jehl-Pietri C; Fredenrich A; Grimaldi PA
    Biochimie; 2004 Nov; 86(11):833-7. PubMed ID: 15589693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis.
    Pesant M; Sueur S; Dutartre P; Tallandier M; Grimaldi PA; Rochette L; Connat JL
    Cardiovasc Res; 2006 Feb; 69(2):440-9. PubMed ID: 16337160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porcine peroxisome proliferator-activated receptor delta mediates the lipolytic effects of dietary fish oil to reduce body fat deposition.
    Yu YH; Wang PH; Cheng WT; Mersmann HJ; Wu SC; Ding ST
    J Anim Sci; 2010 Jun; 88(6):2009-18. PubMed ID: 20190170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.